SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Elbit Imaging Ltd – ‘20-F’ for 12/31/05 – EX-12.1

On:  Friday, 6/30/06, at 3:08pm ET   ·   For:  12/31/05   ·   Accession #:  950123-6-8462   ·   File #:  0-28996

Previous ‘20-F’:  ‘20-F’ on 6/30/05 for 12/31/04   ·   Next:  ‘20-F’ on 7/2/07 for 12/31/06   ·   Latest:  ‘20-F’ on 5/13/19 for 12/31/18

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/30/06  Elbit Imaging Ltd                 20-F       12/31/05   17:2.3M                                   RR Donnelley/FA

Annual Report of a Foreign Private Issuer   —   Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report of a Foreign Private Issuer            287   1.54M 
 2: EX-4.15     Ex-4.15: Framework Transaction Agreement             182    740K 
 3: EX-4.16     Ex-4.16: Share Sale and Purchase Agreement            20     58K 
 4: EX-4.17     Ex-4.17: Unofficial Translation of Deed of Trust      47    178K 
 5: EX-4.18     Ex-4.18: Unofficial Translation of Deed of Trust      47    177K 
 6: EX-4.20     Ex-4.20: Amended and Restated Loan Agreement          76    248K 
 7: EX-4.21     Ex-4.21: Lease Agreement                              59    146K 
 8: EX-4.22     Ex-4.22: Hotel Management Agreement                   64    136K 
 9: EX-4.23     Ex-4.23: Amended and Restated Loan Agreement          72    223K 
10: EX-4.24     Ex-4.24: Amended and Restated Loan Agreement          71    212K 
11: EX-10.1     Ex-10.1: Consent of Brightman Almagor & Co.            1      9K 
12: EX-10.2     Ex-10.2: Consent of Plaza Centers (Europe) B.V.        1      9K 
13: EX-10.3     Ex-10.3: Consent of Bea Hotels N.V.                    1      9K 
14: EX-10.4     Ex-10.4: Consent of Gamida Cell Ltd.                   1      8K 
15: EX-11.1     Ex-11.1: Code of Ethics and Business Conduct           8     38K 
16: EX-12.1     Ex-12.1: Certification                                 2±    11K 
17: EX-13.1     Ex-13.1: Certification                                 1      9K 


EX-12.1   —   Ex-12.1: Certification

EX-12.1TOCTopPreviousNextBottomJust 1st
 

EXHIBIT 12.1 SECTION 302 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER I, Shimon Yitzhaki, certify that: 1. I have reviewed this annual report on Form 20-F of Elbit Medical Imaging Ltd. (the "Company"); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; (b) (Reserved) (c) evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and (d) disclosed in this report any change in the Company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting; and 5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of Company's board of directors (or persons performing the equivalent functions): (a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and (b) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting. Date: June 30, 2006 /s/ Shimon Yitzhaki ------------------------------------- Shimon Yitzhaki President & Chief Financial Officer

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘20-F’ Filing    Date    Other Filings
Filed on:6/30/06
For Period End:12/31/056-K
 List all Filings 
Top
Filing Submission 0000950123-06-008462   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 3:05:54.1am ET